MiMedx Group, Inc. (OTC BB: MDXG)is focused on developing biomaterial-based products for application in the musculoskeletal specialties. The company intends to leverage their experienced management team to commercializes medical technologies by facilitating their progression through the proper regulatory approval processes, arranging for reliable and cost-effective manufacturing, and delivering these products to markets throughout the world. For further information, visit the Company’s web site at www.mimedx.com.
- 18 years ago
QualityStocks
MiMedx Group, Inc. (OTC BB: MDXG)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Closer to Regulatory and Commercial Milestones
Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC hydrogel-based cartilage regeneration technology toward key clinical, regulatory…
-
Wrap Technologies Inc. (NASDAQ: WRAP) Positions Non-Lethal Innovation at the Center of Public Safety Reform
WRAP offerings illustrate a broader industry trend toward building connected ecosystems rather than standalone products.…
-
Brownfield Gold Projects Could Hold an Edge in Today’s Permitting Environment
Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.…